207 related articles for article (PubMed ID: 31481160)
1. AD molecular: Imaging tau aggregates with positron emissions tomography.
Betthauser TJ
Prog Mol Biol Transl Sci; 2019; 165():107-138. PubMed ID: 31481160
[TBL] [Abstract][Full Text] [Related]
2. Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future.
Ariza M; Kolb HC; Moechars D; Rombouts F; Andrés JI
J Med Chem; 2015 Jun; 58(11):4365-82. PubMed ID: 25671691
[TBL] [Abstract][Full Text] [Related]
3. Tau Positron Emission Tomography Imaging.
Kolb HC; Andrés JI
Cold Spring Harb Perspect Biol; 2017 May; 9(5):. PubMed ID: 27940517
[TBL] [Abstract][Full Text] [Related]
4. Discovery of 2-(4-(2-fluoroethoxy)piperidin-1-yl)-9-methyl-9H-pyrrolo[2,3-b:4,5-c']dipyridine ([18F]PI-2014) as PET tracer for the detection of pathological aggregated tau in Alzheimer's disease and other tauopathies.
Gabellieri E; Capotosti F; Molette J; Sreenivasachary N; Mueller A; Berndt M; Schieferstein H; Juergens T; Varisco Y; Oden F; Schmitt-Willich H; Hickman D; Dinkelborg L; Stephens A; Pfeifer A; Kroth H
Eur J Med Chem; 2020 Oct; 204():112615. PubMed ID: 32771872
[TBL] [Abstract][Full Text] [Related]
5. Quantification of Tau Load in Alzheimer's Disease Clinical Trials Using Positron Emission Tomography.
Timmers T; van Berckel BNM; Lammertsma AA; Ossenkoppele R
Methods Mol Biol; 2018; 1750():221-229. PubMed ID: 29512076
[TBL] [Abstract][Full Text] [Related]
6. Neuronal PET tracers for Alzheimer's disease.
Prem Kumar A; Singh N; Nair D; Justin A
Biochem Biophys Res Commun; 2022 Jan; 587():58-62. PubMed ID: 34864547
[TBL] [Abstract][Full Text] [Related]
7. Developments in Tau PET Imaging.
Zimmer ER; Leuzy A; Gauthier S; Rosa-Neto P
Can J Neurol Sci; 2014 Sep; 41(5):547-53. PubMed ID: 25424608
[TBL] [Abstract][Full Text] [Related]
8. Candidate PET Radioligand Development for Neurofibrillary Tangles: Two Distinct Radioligand Binding Sites Identified in Postmortem Alzheimer's Disease Brain.
Cai L; Qu B; Hurtle BT; Dadiboyena S; Diaz-Arrastia R; Pike VW
ACS Chem Neurosci; 2016 Jul; 7(7):897-911. PubMed ID: 27171905
[TBL] [Abstract][Full Text] [Related]
9. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain].
Watanabe H
Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372
[TBL] [Abstract][Full Text] [Related]
10. Advances in the development of tau PET radiotracers and their clinical applications.
Okamura N; Harada R; Furukawa K; Furumoto S; Tago T; Yanai K; Arai H; Kudo Y
Ageing Res Rev; 2016 Sep; 30():107-13. PubMed ID: 26802556
[TBL] [Abstract][Full Text] [Related]
11. Neuroimaging of Alzheimer's disease: focus on amyloid and tau PET.
Matsuda H; Shigemoto Y; Sato N
Jpn J Radiol; 2019 Nov; 37(11):735-749. PubMed ID: 31493197
[TBL] [Abstract][Full Text] [Related]
12. Preclinical Evaluation of
Honer M; Gobbi L; Knust H; Kuwabara H; Muri D; Koerner M; Valentine H; Dannals RF; Wong DF; Borroni E
J Nucl Med; 2018 Apr; 59(4):675-681. PubMed ID: 28970331
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of Tau and Its Ligands in PET Imaging.
Harada R; Okamura N; Furumoto S; Tago T; Yanai K; Arai H; Kudo Y
Biomolecules; 2016 Jan; 6(1):7. PubMed ID: 26751494
[TBL] [Abstract][Full Text] [Related]
14. Tau PET Imaging for Staging of Alzheimer's Disease in Down Syndrome.
Rafii MS
Dev Neurobiol; 2019 Jul; 79(7):711-715. PubMed ID: 30536948
[TBL] [Abstract][Full Text] [Related]
15. PET imaging of tau protein targets: a methodology perspective.
Lois C; Gonzalez I; Johnson KA; Price JC
Brain Imaging Behav; 2019 Apr; 13(2):333-344. PubMed ID: 29497982
[TBL] [Abstract][Full Text] [Related]
16. PET and SPECT Radiotracers for Alzheimer's Disease.
Oukoloff K; Cieslikiewicz-Bouet M; Chao S; Da Costa Branquinho E; Bouteiller C; Jean L; Renard PY
Curr Med Chem; 2015; 22(28):3278-304. PubMed ID: 26242258
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal Assessment of Tau Pathology in Patients with Alzheimer's Disease Using [18F]THK-5117 Positron Emission Tomography.
Ishiki A; Okamura N; Furukawa K; Furumoto S; Harada R; Tomita N; Hiraoka K; Watanuki S; Ishikawa Y; Tago T; Funaki Y; Iwata R; Tashiro M; Yanai K; Kudo Y; Arai H
PLoS One; 2015; 10(10):e0140311. PubMed ID: 26461913
[TBL] [Abstract][Full Text] [Related]
18. Tau PET imaging in Alzheimer's disease.
Okamura N; Harada R; Furumoto S; Arai H; Yanai K; Kudo Y
Curr Neurol Neurosci Rep; 2014 Nov; 14(11):500. PubMed ID: 25239654
[TBL] [Abstract][Full Text] [Related]
19. Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions.
Villemagne VL; Doré V; Burnham SC; Masters CL; Rowe CC
Nat Rev Neurol; 2018 Apr; 14(4):225-236. PubMed ID: 29449700
[TBL] [Abstract][Full Text] [Related]
20. Novel PET/SPECT probes for imaging of tau in Alzheimer's disease.
Watanabe H; Ono M; Saji H
ScientificWorldJournal; 2015; 2015():124192. PubMed ID: 25879047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
